RTC
EW icon

Riverview Trust Company’s Edwards Lifesciences EW Stock Holding History

Riverview Trust Company’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-516
Closed -$40.4K – 211
2025
Q2 		$40.4K Buy
516
+159
+45% +$11.9K 0.05% 136
2025
Q1 		$25.9K Sell
357
-10
-3% -$716 0.03% 341
2024
Q4 		$27.2K Sell
367
-8
-2% -$560 0.02% 347
2024
Q3 		$24.7K Buy
375
+18
+5% +$1.31K 0.02% 382
2024
Q2 		$33K Hold
357
– – 0.03% 291
2024
Q1 		$34.1K Buy
+357
New +$30K 0.03% 305
2023
Q3 		– Sell
-163
Closed -$15.4K – 690
2023
Q2 		$15.4K Buy
+163
New +$14.2K 0.01% 503
2022
Q3 		– Sell
-279
Closed -$27K – 765
2022
Q2 		$27K Sell
279
-248
-47% -$25.7K 0.02% 308
2022
Q1 		$62K Buy
+527
New +$59.1K 0.05% 193

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Riverview Trust Company's EW Position: Q3 2025 in Review

Riverview Trust Company sold out of Edwards Lifesciences (EW) in Q3 2025, closing a stake of 516 shares — an estimated $40.4K sold.

Riverview Trust Company first reported a position in EW in Q1 2022 and held it in 9 quarters. The position peaked at $62K in Q1 2022. 1,254 funds tracked by Wall St. Rank hold EW as of Q3 2025.

  • Riverview Trust Company reported no remaining Edwards Lifesciences position as of Q3 2025 after selling out during the quarter.
  • Riverview Trust Company sold 516 Edwards Lifesciences shares in Q3 2025, an estimated $40.4K.
  • Riverview Trust Company first reported a position in Edwards Lifesciences in Q1 2022 and held it in 9 quarters.
  • Riverview Trust Company's Edwards Lifesciences position peaked at $62K in Q1 2022.
  • 1,254 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on Riverview Trust Company's 13F filing for Q3 2025, filed 22 Oct 2025.